Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | Monsanto's seed and genomics segment net sales 2017

Monsanto's seed and genomics segment net sales 2011-2017

Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data illustrates agrochemical company Monsanto's net sales in the seed and genomics segment from 2011 to 2017, by specialty. In 2017, the corn seed and traits specialty came to approx. 6.27 billion USD of net sales. Monsanto was an agricultural company specialized on genetically engineered seeds. The company was headquartered in St Louis, Missouri. In September 2016, Bayer finalized a deal to take Monsanto over, which is expected to be completed in January 2018 if it passes regulatory approval from the European Union.

2011 4805 1542 895 847
2012 5814 1771 851 779
2013 6596 1653 821 695
2014 6401 2102 867 665
2015 5953 2276 816 523
2016 5825 2162 801 440
2017 6270 2662 815 615